Minerals Technologies Invests in Turkey Plant to Boost Rafinol Production-February 2024-www.financetom.com

Minerals Technologies Invests in Turkey Plant to Boost Rafinol Production

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Minerals Technologies Invests in Turkey Plant to Boost Rafinol Production

Oct 20, 2025 8:31 AM

11:10 AM EDT, 10/20/2025 (MT Newswires) -- Minerals Technologies ( MTX ) said Monday it invested in its plant in Usak, Turkey, to support the growth of its Rafinol product line used in the natural oil purification market.

No financial details were disclosed.

The company said the facility supplies Rafinol, which is used in the production of adsorbents and bleaching earth for purifying renewable fuels and edible oils.

Shares of Minerals Technologies ( MTX ) were up nearly 2% in recent trading.

Price: 60.40, Change: +1.13, Percent Change: +1.91

Previous page： Tidewater Q4 Earnings Flat, Revenue Rises; Full-Year Revenue Guidance Set Next page： Clover Health Q4 Loss Narrows, Revenue Rises

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Tidewater Q4 Earnings Flat, Revenue Rises; Full-Year Revenue Guidance Set

Feb 27, 2025

05:40 PM EST, 02/27/2025 (MT Newswires) -- Tidewater (TDW) reported Q4 earnings late Thursday of $0.70 per diluted share, unchanged from a year earlier. Analysts surveyed by FactSet expected $0.90. Revenue for the quarter ended Dec. 31 was $345.1 million, up from $302.7 million a year earlier. Analysts surveyed by FactSet expected $340.6 million. The company said it expects full-year...

Clover Health Q4 Loss Narrows, Revenue Rises

Feb 27, 2025

05:40 PM EST, 02/27/2025 (MT Newswires) -- Clover Health Investments ( CLOV ) posted a Q4 diluted loss Thursday of $0.04 per share, narrowing from $0.14 a year earlier. Four analysts polled by FactSet expected a loss of $0.07. Revenue for the quarter ended Dec. 31 was $337 million, up from $312.4 million a year earlier. Analysts surveyed by FactSet...

Bridgebio Pharma Insider Sold Shares Worth $282,115, According to a Recent SEC Filing

Feb 27, 2025

05:43 PM EST, 02/27/2025 (MT Newswires) -- Brian C Stephenson, CFO and Treasurer, on February 25, 2025, sold 8,500 shares in Bridgebio Pharma ( BBIO ) for $282,115. Following the Form 4 filing with the SEC, Stephenson has control over a total of 102,464 common shares of the company, with 102,464 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1743881/000095017025029262/xslF345X05/ownership.xml ...

Perrigo Q4 Adjusted Earnings Increase, Sales Decline

Feb 27, 2025

05:41 PM EST, 02/27/2025 (MT Newswires) -- Perrigo ( PRGO ) reported Q4 adjusted earnings late Thursday of $0.93 per diluted share, up from $0.86 a year earlier. Analysts polled by FactSet expected $0.92. Net sales for the quarter that ended Dec. 31 were $1.14 billion, down from $1.16 billion a year earlier. Analysts surveyed by FactSet expected $1.19 billion....